Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
X www.clinicaltrials.gov. Once you are on the website, type
“NCT03362593” into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D8170C00001” into the search box, and click “Find a Study”.
Full Study Title: A Phase 1 Single and Multiple Ascending Dose Study
to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI7219 in
Healthy Subjects, including Assessment of the Impact of Changes to the Oral
Formulation and Determination of Intravenous Pharmacokinetics
AstraZeneca Protocol Number: D8170C00001
National Clinical Trials Number: NCT03362593
MedImmune, LLC sponsored this study and has its headquarters in
Gaithersburg, MD, USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants and their families belong to a large community of
people who take part in clinical research around the world. They help researchers
answer important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_08_31
12 | Clinical Study Results